Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia
- 881 Downloads
To study the mesolimbic dopamine system during expectation and receipt or omission of rewards in partially remitted patients with schizophrenia treated with the atypical antipsychotic olanzapine.
We studied 16 patients with a current episode of schizophrenia, all treated with the atypical drug olanzapine, and 16 healthy subjects using functional magnetic resonance imaging. Subjects performed a delayed incentive paradigm with monetary rewards.
During reward expectation, both, patients with schizophrenia and healthy control subjects, showed activation of the ventral striatum and midbrain in the vicinity of the ventral tegmental area. Significant categorical group differences emerged in the anterior cingulate cortex with only healthy controls showing increasing activation with increasing reward. In the patients, activation of this region was inversely correlated with positive symptoms. During outcome, both, patients with schizophrenia and healthy controls, showed activation of the ventral striatum and the mesial prefrontal cortex. Significant categorical group differences emerged in the right ventrolateral prefrontal cortex for the salience contrast with healthy controls showing a U-shaped activation curve, i.e., higher activation for either omission or receipt of reward compared to no reward.
Our findings partially support the current concept of dopaminergic dysfunction in schizophrenia, suggesting a rather hyperactive mesolimbic dopamine system and reduced prefrontal activation, at least in partially remitted patients treated with atypical antipsychotics.
KeywordsfMRI Schizophrenia Reward Dopamine Positive and negative symptoms
Thanks to Christian Wolf for the thorough expert review of the final draft of the paper.
The experiments comply with the current laws of the country in which they were performed.
Acknowledgement of funding
The study was supported in part by a personal grant to Birgit Abler from the DAAD (German Academic Exchange Service).
- Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharm Toxicol (Copenh) 20:140–144Google Scholar
- Fornito A, Yucel M, Dean B, Wood SJ, Pantelis C (2008) Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology. Schizophr Bull doi: 10.1093/schbul/sbn025
- Hautzinger M, Bailer M, Worall H, Keller F (1995) Beck-Depressions-Inventar (BDI); Testhandbuch. Hans Huber, Hans HuberGoogle Scholar
- Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wustenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A (2006b) Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) 187:222–228CrossRefGoogle Scholar
- Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW (2008) A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 65:746–760PubMedCrossRefGoogle Scholar
- Macdonald AW, 3rd, Thermenos HW, Barch DM, Seidman LJ (2008) Imaging Genetic Liability to Schizophrenia: Systematic Review of fMRI Studies of Patients’ Nonpsychotic Relatives. Schizophr BullGoogle Scholar